The burgeoning popularity of tirzepatide , initially for metabolic conditions, is creating significant buzz within the British Isles, prompting a notable shift in medication trends. Access these compounds remains a complex challenge , with National Health Service coverage currently limited and private clinics offering prescriptions at a premium . W